A functional inflammasome activation assay differentiates patients with pathogenic NLRP3 mutations and symptomatic patients with low penetrance variants

Autor: Rieber, Nikolaus, Gavrilov, Alina, Hofer, Laura, Singh, Anurag, Öz, Hasan, Endres, Theresa, Schäfer, Iris, Handgretinger, Rupert, Hartl, Dominik, Kuemmerle-Deschner, Jasmin
Zdroj: In Clinical Immunology March 2015 157(1):56-64
Databáze: ScienceDirect